Intriguingly, Glucagon-like peptide-1 (GLP-1) agonists prescribed for weight loss (see section below on treatment of obstructive sleep apnea) also can substantially reduce alcohol use (8). The gene discussed is GCG; the disease is obstructive sleep apnea syndrome.